Live Breaking News & Updates on Bengaluru Based Strides Pharma Science

Stay updated with breaking news from Bengaluru based strides pharma science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

A Case of Slipping Quality

A Case of Slipping Quality
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Andhra Pradesh , Madhya Pradesh , Republic Of , Galentic Pharma , States Pharmacopeia , Zydus Lifesciences , Intas Pharma , Mansukh Mandaviya , Girdhar Balwani , Aurobindo Pharma , Bayer Pharma , Ranjan Chakrabarti , Manoj Saxena , Glenmark Pithampur Madhya Pradesh , Parawada Mandal , Sudarshan Jain , Jawaharlal Nehru Pharma , Sun Pharma , Rajeev Singh Raghuvanshi , Cipla United States Inc , Reddy Lab , Central Drugs Standard Control Organisation , Maiden Pharmaceuticals , International Pharmaceutical Exhibition , Intas Pharmaceuticals , Union Health ,

Strides and Orbicular enter into strategic partnership to develop range of nasal sprays

Strides to launch the products globally through its commercial arms ....

Andhra Pradesh , New York , United States , Chestnut Ridge , Drug Enforcement Administration , Nendo Inc , Bengaluru Based Strides Pharma Science , Orbicular Pharmaceutical Technologies , Nasal Spray ,

Strides Pharma teams up with Ennaid Therapeutics to manufacture COVID-19 drug

Strides Pharma teams up with Ennaid Therapeutics to manufacture COVID-19 drug
Strides Pharma teams up with Ennaid Therapeutics to manufacture COVID-19 drug
15 June 2021 | News
Ennaid Therapeutics will produce an oral, repurposed medication to treat mild, moderate and asymptomatic cases of COVID‐19
Image Credit: shutterstock.com
Bengaluru-based Strides Pharma Science has announced that its step‐down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore has entered into an exclusive partnership with US-based Ennaid Therapeutics, a global pharmaceutical company to produce an oral, repurposed medication to treat mild, moderate and asymptomatic cases of COVID‐19.
Ennaid’s partnership with discovery scientists at Universidad Católica de Murcia (UCAM), identified a therapeutic target to treat COVID‐19 using artificial intelligence drug discovery platforms. ....

United States , Bengaluru Based Strides Pharma Science , Strides Pharma Global , Ennaid Therapeutics , Universidad Cat , Managing Director , ஒன்றுபட்டது மாநிலங்களில் , பெங்களூரு அடிப்படையிலானது முன்னேற்றங்கள் பார்மா அறிவியல் , முன்னேற்றங்கள் பார்மா உலகளாவிய , யுனிவர்சிடாட் பூனை , நிர்வகித்தல் இயக்குனர் ,

India emerges global manufacturing hub for Covid-19 vaccine Sputnik V

Hyderabad-headquartered Gland Pharma on Tuesday said it had inked a pact with Russian Direct Investment Fund (RDIF) to supply 252 million doses of the Covid-19 vaccine Sputnik V.
This is part of the Russian sovereign wealth fund’s efforts to increase manufacturing capacities in India to make for the country and to augment global supplies.
Sources said Bengaluru-based Strides Pharma Science, too, is in fray for contract manufacturing the Sputnik V. Another Hyderabad-based player, Hetero, will supply 100 million doses of the vaccine.
RDIF has lined up 250 million doses for India over the next 12 months, and the rest will be for global supplies. ....

South Korea , November Kirill Dimitriev , Gamaleya National Research Institute Of Epidemiology , China Gland Pharmaceuticals , Serum Institute Of India , Russian Direct Investment Fund , Hyderabad Headquartered Gland Pharma , Bengaluru Based Strides Pharma Science , Serum Institute , Bharat Biotech , Gland Pharma , Fosun Backed Gland Pharmaceuticals , Gamaleya National Research Institute , Coronavirus Vaccine , Pharma Companies , Sputnik V , தெற்கு கொரியா , சீனா சுரப்பி மருந்துகள் , சீரம் நிறுவனம் ஆஃப் இந்தியா , ரஷ்ய நேரடி முதலீடு நிதி , பெங்களூரு அடிப்படையிலானது முன்னேற்றங்கள் பார்மா அறிவியல் , சீரம் நிறுவனம் , பாரத் பயோடெக் , சுரப்பி பார்மா , பார்மா நிறுவனங்கள் , ஸ்பட்நிக் வ் ,

Cipla recalls 5.8 lakh packets of gastric ulcer treatment drug from US market

Cipla recalls 5.8 lakh packets of gastric ulcer treatment drug from US market
The drug firm has manufactured the affected lot at its Kurkumbh facility in Maharashtra and then supplied to its New Jersey-based subsidiary
PTI | January 10, 2021 | Updated 14:07 IST
The USFDA cited cross-contamination with other products as the reason for the company recalling the product
Drug major Cipla is recalling over 5.8 lakh packets of a drug for the reduction in the occurrence of gastric ulcers from the US market, as per a report by the US Food and Drug Administration. The drug major is recalling esomeprazole magnesium for delayed-release oral suspension in unit dose packets in strengths 10 mg, 20 mg and 40 mg in the US market, the latest Enforcement Report by the USFDA said. ....

Strides Pharma Inc , Drug Administration , Enforcement Report , New Jersey Based , Bengaluru Based Strides Pharma Science , Us Food And Drug Administration , Cipla Us Market , Cipla Gastric Ulcer Treatment , Cipla Gastric Ulcer Treatment Packets , Cipla Gastric Ulcer Treatment In Us , Cipla Gastric Ulcer Treatment Us Market , Cipla Gastric Ulcer Treatment Recalled From Us Mark , முன்னேற்றங்கள் பார்மா இன்க் , அமலாக்கம் அறிக்கை , புதியது ஜெர்சி அடிப்படையிலானது , பெங்களூரு அடிப்படையிலானது முன்னேற்றங்கள் பார்மா அறிவியல் , சிப்லா எங்களுக்கு சந்தை , சிப்லா இரைப்பை புண் சிகிச்சை , சிப்லா இரைப்பை புண் சிகிச்சை ப்யாகெட்ஸ் , சிப்லா இரைப்பை புண் சிகிச்சை இல் எங்களுக்கு , சிப்லா இரைப்பை புண் சிகிச்சை எங்களுக்கு சந்தை ,